NCT05965180 Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
| NCT ID | NCT05965180 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan Rogel Cancer Center |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-10-16 |
| Primary Completion | 2027-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-10-16 with a primary completion date of 2027-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding tissue without any tissue extraction. The needle probe has been tested in prostate tissue samples and whole human prostates ex vivo.
Eligibility Criteria
Inclusion Criteria: * 1\) Planned prostate biopsy as part of routine clinical care * 2\) \> 40 and \<80 years old Exclusion Criteria: * 1\) Known history of bleeding disorders or * 2\) Patients taking anticoagulants, no matter doses or washout time * 3\) Known allergy to silicone material * 4\) Unable to provide informed consent * 5\) Either the surgeon or the patient do not think the patient will not be able to complete all parts of the study, the patient will be excluded * 6\) Involved in other investigational studies.
Contact & Investigator
Guan Xu, Phd
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT05965180 clinical trial?
This trial is open to male participants only, aged 40 Years or older, up to 80 Years, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05965180 currently recruiting?
Yes, NCT05965180 is actively recruiting participants. Contact the research team at CancerAnswerLine@med.umich.edu for enrollment information.
Where is the NCT05965180 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT05965180 clinical trial?
NCT05965180 is sponsored by University of Michigan Rogel Cancer Center. The principal investigator is Guan Xu, Phd at University of Michigan. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.